Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 13, 2022
Patent Application Number
16500947
Date Filed
July 19, 2019
Patent Citations
Patent Primary Examiner
The present invention relates to anti-human CD226 agonist antibodies, which can be useful for treating solid tumor cancers.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.